Security Snapshot

BridgeBio Pharma, Inc. - Common Stock (BBIO) Institutional Ownership

CUSIP: 10806X102

13F Institutional Holders and Ownership History from Q2 2019 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

475

Shares (Excl. Options)

193.65MFull value: 193,646,489 · shares · 30 Jun 2026

Price

$74.48

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
BBIO on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
193,646,489
Latest holder snapshot 5 signals
Total 13F value
$14,414,850,583
Portfolio coverage rank
0.02%
Share change
-1,331,173
Value change
-$99,973,754
Number of holders
475
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
193,965,216
SEC-reported price per share
$65.80
Insider filing price
$65.80
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • BBIO - BridgeBio Pharma, Inc. - Common Stock is tracked under CUSIP 10806X102.
  • 475 institutions reported positions in Q2 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 462 to 475 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $14.42BFull value: $14,422,832,660 · USD · 31 Mar 2026
    to
    $14.41BFull value: $14,414,850,583 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 475 institutions filings for Q2 2026.

Open SEC evidence

Security key

10806X102

13F reference period

Q2 2026

13F holders

475

13D/G owners

7

CIK / CUSIP context first

Open Q2 2026 holders BBIO full holder history BridgeBio Pharma, Inc. SEC filings BridgeBio Pharma, Inc. company facts BridgeBio Pharma, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
BBIO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 6.8% +18% $977,092,024 +$161,518,142 13,179,013 +20% JANUS HENDERSON GROUP PLC 31 Mar 2026
FARALLON CAPITAL MANAGEMENT, L.L.C. 5.5% $836,992,038 10,743,063 Farallon Capital Management, L.L.C. 30 Jun 2026
Farallon Capital Partners, L.P. 5.2% $674,408,855 10,226,063 Dapice Joshua J. 22 May 2026
BlackRock, Inc. 5.1% +2.8% $650,908,471 +$10,426,931 9,892,226 +1.6% BlackRock, Inc. 30 Sep 2026
VIKING GLOBAL INVESTORS LP 5% -18% $729,325,450 -$152,700,218 9,792,219 -17% VIKING GLOBAL INVESTORS LP 09 Jul 2026
Kumar Neil 4.6% -16% $689,354,243 -$87,903,790 9,282,982 -11% NEIL KUMAR 31 Mar 2026
KKR Genetic Disorder L.P. 4.7% -33% $719,322,695 -$313,839,555 9,232,739 -30% KKR Group Partnership L.P. 13 Aug 2026
As of 30 Jun 2026, 475 institutional investors reported holding
193.65MFull value: 193,646,489 · shares · 30 Jun 2026
shares of BridgeBio Pharma, Inc. - Common Stock (BBIO). This represents 100% of the company’s total
193.97MFull value: 193,965,216 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
66%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Jupiter Topco LLC 7.3% 14,110,278 0% 0.43% $1,050,761,525
Kohlberg Kravis Roberts & Co. L.P. 6.8% 13,260,971 0% 17% $987,677,120
FARALLON CAPITAL MANAGEMENT, L.L.C. 5.5% 10,743,063 +15% 4.7% $800,143,332
BlackRock, Inc. 5.3% 10,287,156 -28% 0.01% $766,187,363
VIKING GLOBAL INVESTORS LP 5.1% 9,949,219 -16% 2.1% $741,017,831
VANGUARD CAPITAL MANAGEMENT LLC 4.1% 7,898,973 +1.8% 0.01% $588,315,509
VANGUARD PORTFOLIO MANAGEMENT LLC 3.9% 7,656,722 -5.2% 0.03% $570,272,655
WELLINGTON MANAGEMENT GROUP LLP 2.7% 5,308,924 +114% 0.07% $395,408,660
TWO SIGMA INVESTMENTS, LP 2.4% 4,722,185 +51% 0.26% $351,708,339
Aisling Capital Management LP 2.4% 4,589,611 -9.8% 72% $341,834,227
STATE STREET CORP 2.3% 4,435,932 -10% 0.01% $330,388,215
CITADEL ADVISORS LLC 1.9% 3,760,028 +18% 0.16% $280,046,885
Invesco Ltd. 1.9% 3,700,934 -19% 0.02% $275,645,564
D. E. Shaw & Co., Inc. 1.9% 3,633,007 +43% 0.17% $270,586,362
GEODE CAPITAL MANAGEMENT, LLC 1.8% 3,418,419 -30% 0.01% $254,669,075
JANE STREET GROUP, LLC 1.5% 2,934,193 +67% 0.14% $218,538,695
JPMORGAN CHASE & CO 1.2% 2,397,995 +83% 0.01% $173,229,954
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.2% 2,252,000 +276% 0.24% $167,728,960
FRANKLIN RESOURCES INC 1.1% 2,160,173 -11% 0.03% $160,889,674
Polar Capital Holdings Plc 1.1% 2,063,609 -18% 0.44% $153,697,598
FMR LLC 1.1% 2,061,307 -12% 0.01% $153,526,176
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1% 1,955,733 -1.1% 0.11% $145,662,994
SC US (TTGP), LTD. 0.96% 1,860,364 0% 0.43% $138,559,911
GOLDMAN SACHS GROUP INC 0.94% 1,814,657 -4.4% 0.01% $135,155,654
UBS Group AG 0.91% 1,757,152 -13% 0.02% $130,872,681

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
30
Headline period
Q2 2026
Rows shown
1-25 of 30
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 497,817 $32,766,088 -$1,909,031 $65.80 88
2026 Q2 193,646,489 $14,414,850,583 -$99,973,754 $74.48 475
2026 Q1 194,185,579 $14,422,832,660 +$364,041,432 $74.26 462
2025 Q4 188,214,200 $14,404,286,659 +$186,537,774 $76.49 429
2025 Q3 184,963,434 $9,606,937,258 -$158,160,333 $51.94 389
2025 Q2 188,818,044 $8,154,464,813 +$171,957,099 $43.18 357
2025 Q1 185,173,982 $6,405,659,483 +$325,204,372 $34.57 302
2024 Q4 176,645,317 $4,847,193,349 +$87,655,048 $27.44 260
2024 Q3 172,596,886 $4,393,814,683 -$68,086,150 $25.46 251
2024 Q2 174,953,530 $4,431,556,073 +$57,307,408 $25.33 249
2024 Q1 171,539,419 $5,303,582,949 +$162,256,099 $30.92 240
2023 Q4 165,715,337 $6,690,573,516 +$142,779,397 $40.37 246
2023 Q3 161,102,840 $4,243,730,776 +$304,390,990 $26.37 219
2023 Q2 149,815,028 $2,576,329,186 -$39,862,601 $17.20 196
2023 Q1 152,372,388 $2,526,139,807 +$155,256,748 $16.58 210
2022 Q4 144,623,389 $1,101,997,850 -$14,634,842 $7.62 175
2022 Q3 145,248,661 $1,443,911,522 +$48,733,339 $9.94 170
2022 Q2 140,449,294 $1,275,283,327 -$23,547,672 $9.08 153
2022 Q1 143,303,557 $1,454,787,082 -$23,988,513 $10.15 167
2021 Q4 141,976,495 $2,367,117,577 -$117,448,257 $16.68 181
2021 Q3 140,028,398 $6,563,888,337 -$165,004,819 $46.87 206
2021 Q2 142,676,491 $8,697,122,835 +$97,636,690 $60.96 197
2021 Q1 141,085,070 $8,688,930,801 +$1,238,074,220 $61.60 194
2020 Q4 121,079,579 $8,609,553,572 +$172,667,185 $71.11 160
2020 Q3 117,841,767 $4,393,419,330 +$21,644,575 $37.52 128
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .